Literature DB >> 7051408

Rapid isolation of high molecular weight urokinase from native human urine.

K Huber, J Kirchheimer, B R Binder.   

Abstract

Urokinase (UK) could be purified to apparent homogeneity starting from crude urine by sequential adsorption and elution of the enzyme to gelatine-Sepharose and agmatine-Sepharose followed by gel filtration on Sephadex G-150. The purified product exhibited characteristics of the high molecular weight urokinase (HMW-UK) but did contain two distinct entities, one of which exhibited a two chain structure as reported for the HMW-UK while the other one exhibited an apparent single chain structure. The purification described is rapid and simple and results in an enzyme with probably no major alterations. Yields are high enough to obtain purified enzymes for characterization of UK from individual donors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051408

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

Review 1.  Physiology and pathophysiology of the plasminogen system in the kidney.

Authors:  Per Svenningsen; Gitte Rye Hinrichs; Rikke Zachar; Rikke Ydegaard; Boye L Jensen
Journal:  Pflugers Arch       Date:  2017-06-27       Impact factor: 3.657

2.  Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney.

Authors:  S N Wagner; M J Atkinson; C Wagner; H Höfler; M Schmitt; O Wilhelm
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

3.  The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study.

Authors:  C Häckel; K Radig; I Röse; A Roessner
Journal:  Anat Embryol (Berl)       Date:  1995-10

4.  Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.

Authors:  S N Wagner; M J Atkinson; S Thanner; C Wagner; M Schmitt; O Wilhelm; M Rotter; H Höfler
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.